Federal award (DELIVERY ORDER, fiscal year 2023)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2024-03-14 to 2024-04-04
Current total value of award: $9284.4
Description: 4564016045!XOLAIR 150 MG/ML SYRINGEML